{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:11:08Z","timestamp":1793063468972,"version":"4.5.0"},"reference-count":207,"publisher":"BMJ","issue":"1","funder":[{"DOI":"10.13039\/100013791","name":"Bowel Cancer UK","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013791","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Norman Foster Foundation"},{"name":"Tom Simms Memorial Fund at Queen\u2019s University Belfast"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2017,10,25]]},"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Colorectal cancer (CRC) leads to significant morbidity\/mortality worldwide. Defining critical research gaps (RG), their prioritisation and resolution, could improve patient outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>RG analysis was conducted by a multidisciplinary panel of patients, clinicians and researchers (n=71). Eight working groups (WG) were constituted: discovery science; risk; prevention; early diagnosis and screening; pathology; curative treatment; stage IV disease; and living with and beyond CRC. A series of discussions led to development of draft papers by each WG, which were evaluated by a 20-strong patient panel. A final list of RGs and research recommendations (RR) was endorsed by all participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Fifteen critical RGs are summarised below:\n                      <jats:italic>RG1<\/jats:italic>\n                      : Lack of realistic models that recapitulate tumour\/tumour micro\/macroenvironment;\n                      <jats:italic>RG2<\/jats:italic>\n                      : Insufficient evidence on precise contributions of genetic\/environmental\/lifestyle factors to CRC risk;\n                      <jats:italic>RG3<\/jats:italic>\n                      : Pressing need for prevention trials;\n                      <jats:italic>RG4<\/jats:italic>\n                      : Lack of integration of different prevention approaches;\n                      <jats:italic>RG5<\/jats:italic>\n                      : Lack of optimal strategies for CRC screening;\n                      <jats:italic>RG6<\/jats:italic>\n                      : Lack of effective triage systems for invasive investigations;\n                      <jats:italic>RG7<\/jats:italic>\n                      : Imprecise pathological assessment of CRC;\n                      <jats:italic>RG8<\/jats:italic>\n                      : Lack of qualified personnel in genomics, data sciences and digital pathology;\n                      <jats:italic>RG9<\/jats:italic>\n                      : Inadequate assessment\/communication of risk, benefit and uncertainty of treatment choices;\n                      <jats:italic>RG10<\/jats:italic>\n                      : Need for novel technologies\/interventions to improve curative outcomes;\n                      <jats:italic>RG11<\/jats:italic>\n                      : Lack of approaches that recognise molecular interplay between metastasising tumours and their microenvironment;\n                      <jats:italic>RG12<\/jats:italic>\n                      : Lack of reliable biomarkers to guide stage IV treatment;\n                      <jats:italic>RG13<\/jats:italic>\n                      : Need to increase understanding of health related quality of life (HRQOL) and promote residual symptom resolution;\n                      <jats:italic>RG14<\/jats:italic>\n                      : Lack of coordination of CRC research\/funding;\n                      <jats:italic>RG15<\/jats:italic>\n                      : Lack of effective communication between relevant stakeholders.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Prioritising research activity and funding could have a significant impact on reducing CRC disease burden over the next 5 years.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2017-315333","type":"journal-article","created":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T05:25:13Z","timestamp":1513056313000},"page":"179-193","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":84,"title":["Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer"],"prefix":"10.1136","volume":"67","author":[{"given":"Mark","family":"Lawler","sequence":"first","affiliation":[{"name":"Centre for Cancer Research and Cell Biology, Queen\u2019s University Belfast, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Alsina","sequence":"additional","affiliation":[{"name":"Bowel Cancer UK, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Adams","sequence":"additional","affiliation":[{"name":"School of Medicine, Cardiff University, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie S","family":"Anderson","sequence":"additional","affiliation":[{"name":"Research into Cancer Prevention and Screening, University of Dundee, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Radiology, Royal Marsden Hospital, Sutton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola S","family":"Fearnhead","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Addenbrooke\u2019s Hospital, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W","family":"Fenwick","sequence":"additional","affiliation":[{"name":"Hepatobiliary Surgery Unit, Aintree University Hospital, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7583-5764","authenticated-orcid":false,"given":"Stephen P","family":"Halloran","sequence":"additional","affiliation":[{"name":"Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hochhauser","sequence":"additional","affiliation":[{"name":"Department of Oncology, University College London Cancer Institute, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7414-1576","authenticated-orcid":false,"given":"Mark A","family":"Hull","sequence":"additional","affiliation":[{"name":"Leeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor H","family":"Koelzer","sequence":"additional","affiliation":[{"name":"Molecular and Population Genetics Laboratory, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus G K","family":"McNair","sequence":"additional","affiliation":[{"name":"Centre for Surgical Research, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7918-4003","authenticated-orcid":false,"given":"Kevin J","family":"Monahan","sequence":"additional","affiliation":[{"name":"Family History of Bowel Cancer Clinic, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2420-4385","authenticated-orcid":false,"given":"Inke","family":"N\u00e4thke","sequence":"additional","affiliation":[{"name":"School of Life Sciences, University of Dundee, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Norton","sequence":"additional","affiliation":[{"name":"Florence Nightingale Faculty of Nursing and Midwifery, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco R","family":"Novelli","sequence":"additional","affiliation":[{"name":"Research Department of Pathology, University College London Medical School, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J C","family":"Steele","sequence":"additional","affiliation":[{"name":"Research into Cancer Prevention and Screening, University of Dundee, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne L","family":"Thomas","sequence":"additional","affiliation":[{"name":"Leicester Cancer Research Centre, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M","family":"Wilde","sequence":"additional","affiliation":[{"name":"Bowel Cancer UK, London, UK"},{"name":"Atticus Consultants Ltd, Croydon, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H","family":"Wilson","sequence":"additional","affiliation":[{"name":"Centre for Cancer Research and Cell Biology, Queen\u2019s University Belfast, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3037-1470","authenticated-orcid":false,"given":"Ian","family":"Tomlinson","sequence":"additional","affiliation":[{"name":"Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,12,12]]},"reference":[{"key":"2025121304581129000_67.1.179.1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310912"},{"key":"2025121304581129000_67.1.179.2","unstructured":"Cancer Research UK. Bowel cancer statistics. http:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/bowel-cancer (accessed 08 Sep 2017)."},{"key":"2025121304581129000_67.1.179.3","unstructured":"The American Cancer Society. http:\/\/www.cancer.org\/acs\/groups\/content\/@internationalaffairs\/documents\/document\/acspc-026203.pdf (accessed 08 Sep 2017)."},{"key":"2025121304581129000_67.1.179.4","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djq495"},{"key":"2025121304581129000_67.1.179.5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70442-X"},{"key":"2025121304581129000_67.1.179.6","unstructured":"National Cancer Institute. https:\/\/fundedresearch.cancer.gov\/nciportfolio\/search\/get?site=Colon%2fRectum&fy=PUB2014 (accessed 08 Sep 2017)."},{"key":"2025121304581129000_67.1.179.7","unstructured":"Cancer Research UK. How much we spend on research. http:\/\/www.cancerresearchuk.org\/how-much-we-spend-on-research (accessed 08 Sep 2017)."},{"key":"2025121304581129000_67.1.179.8","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3493"},{"key":"2025121304581129000_67.1.179.9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/978-3-319-30654-4_18","article-title":"Focusing the spotlight on the zebrafish intestine to illuminate mechanisms of colorectal cancer","volume":"916","author":"Lobert","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"2025121304581129000_67.1.179.10","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22168"},{"key":"2025121304581129000_67.1.179.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.05.016"},{"key":"2025121304581129000_67.1.179.12","doi-asserted-by":"crossref","first-page":"38737","DOI":"10.18632\/oncotarget.5395","article-title":"Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: are all mutations equal?","volume":"6","author":"Maccaroni","year":"2015","journal-title":"Oncotarget"},{"key":"2025121304581129000_67.1.179.13","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3967"},{"key":"2025121304581129000_67.1.179.14","doi-asserted-by":"crossref","first-page":"15107","DOI":"10.1038\/ncomms15107","article-title":"Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer","volume":"8","author":"Isella","year":"2017","journal-title":"Nat Commun"},{"key":"2025121304581129000_67.1.179.15","doi-asserted-by":"crossref","first-page":"15657","DOI":"10.1038\/ncomms15657","article-title":"Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification","volume":"8","author":"Dunne","year":"2017","journal-title":"Nat Commun"},{"key":"2025121304581129000_67.1.179.16","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3224"},{"key":"2025121304581129000_67.1.179.17","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3225"},{"key":"2025121304581129000_67.1.179.18","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0032"},{"key":"2025121304581129000_67.1.179.19","doi-asserted-by":"publisher","DOI":"10.1126\/science.aai8515"},{"key":"2025121304581129000_67.1.179.20","doi-asserted-by":"crossref","unstructured":"Villalba M , Evans SR , Vidal-Vanaclocha F , et al . Role of TGF-\u03b2 in metastatic colon cancer: it is finally time for targeted therapy. Cell Tissue Res 2017:29\u201339.doi:10.1007\/s00441-017-2633-9","DOI":"10.1007\/s00441-017-2633-9"},{"key":"2025121304581129000_67.1.179.21","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2016.59"},{"key":"2025121304581129000_67.1.179.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.12.029"},{"key":"2025121304581129000_67.1.179.23","doi-asserted-by":"publisher","DOI":"10.1002\/path.4645"},{"key":"2025121304581129000_67.1.179.24","doi-asserted-by":"publisher","DOI":"10.1126\/science.256.5060.1114"},{"key":"2025121304581129000_67.1.179.25","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-11-0109"},{"key":"2025121304581129000_67.1.179.26","doi-asserted-by":"publisher","DOI":"10.1038\/nature07935"},{"key":"2025121304581129000_67.1.179.27","doi-asserted-by":"crossref","unstructured":"Omar Al-Hassi H , Ng O , Brookes M . Tumour-associated and non-tumour-associated microbiota in colorectal cancer. Gut 2017 (Epub ahead of print: 04 May 2017).doi:10.1136\/gutjnl-2017-314219","DOI":"10.1136\/gutjnl-2017-314219"},{"key":"2025121304581129000_67.1.179.28","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/gepi.21967","article-title":"Review of the gene-environment interaction literature in cancer: what do we know?","volume":"40","author":"Simonds","year":"2016","journal-title":"Genet Epidemiol"},{"key":"2025121304581129000_67.1.179.29","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-306705"},{"key":"2025121304581129000_67.1.179.30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11883"},{"key":"2025121304581129000_67.1.179.31","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.465"},{"key":"2025121304581129000_67.1.179.32","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015619","article-title":"The association of dietary quality with colorectal cancer among normal weight, overweight and obese men and women: a prospective longitudinal study in the USA","volume":"7","author":"Torres Stone","year":"2017","journal-title":"BMJ Open"},{"key":"2025121304581129000_67.1.179.33","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-014-0168-4"},{"key":"2025121304581129000_67.1.179.34","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.225011"},{"key":"2025121304581129000_67.1.179.35","doi-asserted-by":"crossref","first-page":"18456","DOI":"10.18632\/oncotarget.14472","article-title":"2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications","volume":"8","author":"Gonz\u00e1lez","year":"2017","journal-title":"Oncotarget"},{"key":"2025121304581129000_67.1.179.36","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.1815"},{"key":"2025121304581129000_67.1.179.37","doi-asserted-by":"publisher","DOI":"10.7326\/M14-0765"},{"key":"2025121304581129000_67.1.179.38","unstructured":"Cancer Prevention Program. Genetics and epidemiology of colorectal cancer consortium (GECCO). http:\/\/www.fredhutch.org\/en\/labs\/phs\/projects\/cancer-prevention\/projects\/gecco.html (accessed 08 Sep 2017)."},{"key":"2025121304581129000_67.1.179.39","unstructured":"National Cancer Institute. Epidemiology and genomics research program. https:\/\/epi.grants.cancer.gov\/gameon\/ (accessed 08 Sep 2017)."},{"key":"2025121304581129000_67.1.179.40","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1053\/j.gastro.2016.02.076","article-title":"Identification of susceptibility loci and genes for colorectal cancer risk","volume":"150","author":"Zeng","year":"2016","journal-title":"Gastroenterology"},{"key":"2025121304581129000_67.1.179.41","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.02.010"},{"key":"2025121304581129000_67.1.179.42","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-15-0649"},{"key":"2025121304581129000_67.1.179.43","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2985"},{"key":"2025121304581129000_67.1.179.44","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1038\/ncomms5613","article-title":"Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A","volume":"5","author":"Wang","year":"2014","journal-title":"Nat Commun"},{"key":"2025121304581129000_67.1.179.45","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2016-104125"},{"key":"2025121304581129000_67.1.179.46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006493","article-title":"Winner\u2019s curse correction and variable thresholding improve performance of polygenic risk modeling based on genome-wide association study summary-level data","volume":"12","author":"Shi","year":"2016","journal-title":"PLoS Genet"},{"key":"2025121304581129000_67.1.179.47","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-14-0062"},{"key":"2025121304581129000_67.1.179.48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004228"},{"key":"2025121304581129000_67.1.179.49","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1053\/j.gastro.2017.04.004","article-title":"High-quality diets associate with reduced risk of colorectal cancer: analyses of diet quality indexes in the multiethnic cohort","volume":"153","author":"Park","year":"2017","journal-title":"Gastroenterology"},{"key":"2025121304581129000_67.1.179.50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006296","article-title":"Genome-wide interaction analyses between genetic variants and alcohol consumption and smoking for risk of colorectal cancer","volume":"12","author":"Gong","year":"2016","journal-title":"PLoS Genet"},{"key":"2025121304581129000_67.1.179.51","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1388"},{"key":"2025121304581129000_67.1.179.52","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c1693"},{"key":"2025121304581129000_67.1.179.53","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/538019"},{"key":"2025121304581129000_67.1.179.54","unstructured":"National Cancer Research Center. How was research funding from NCRI Partners spent in 2015? http:\/\/www.ncri.org.uk\/wp-content\/uploads\/2016\/06\/2016-NCRI-CaRD-210-x-297.pdf (accessed 08 Sep 2017)."},{"key":"2025121304581129000_67.1.179.55","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.58.9952"},{"key":"2025121304581129000_67.1.179.56","unstructured":"World Cancer Research Fund. How was research funding from NCRI Partners spent in 2015? http:\/\/www.wcrf.org\/sites\/default\/files\/CUP_Colorectal_Report_2017_Digital.pdf (accessed 08 Sep 2017)."},{"key":"2025121304581129000_67.1.179.57","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa4972"},{"key":"2025121304581129000_67.1.179.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2016.01.003"},{"key":"2025121304581129000_67.1.179.59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053916","article-title":"Obesity and risk of colorectal cancer: a systematic review of prospective studies","volume":"8","author":"Ma","year":"2013","journal-title":"PLoS One"},{"key":"2025121304581129000_67.1.179.60","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsr1606602"},{"key":"2025121304581129000_67.1.179.61","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604917"},{"key":"2025121304581129000_67.1.179.62","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61049-0"},{"key":"2025121304581129000_67.1.179.63","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.4"},{"key":"2025121304581129000_67.1.179.64","doi-asserted-by":"publisher","DOI":"10.7326\/M16-0577"},{"key":"2025121304581129000_67.1.179.65","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu225"},{"key":"2025121304581129000_67.1.179.66","doi-asserted-by":"crossref","unstructured":"Smith SG , Foy R , McGowan J , et al . General practitioner attitudes towards prescribing aspirin to carriers of Lynch Syndrome: findings from a national survey. Fam Cancer 2017:509\u201316.doi:10.1007\/s10689-017-9986-9","DOI":"10.1007\/s10689-017-9986-9"},{"key":"2025121304581129000_67.1.179.67","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-013-0150-z"},{"key":"2025121304581129000_67.1.179.68","first-page":"326","article-title":"The role of the microbiome in cancer development and therapy","volume":"67","author":"Bhatt","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"2025121304581129000_67.1.179.69","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2015.09.001"},{"key":"2025121304581129000_67.1.179.70","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00384-017-2797-5","article-title":"Lifestyle interventions are feasible in patients with colorectal cancer with potential short-term health benefits: a systematic review","volume":"32","author":"Moug","year":"2017","journal-title":"Int J Colorectal Dis"},{"key":"2025121304581129000_67.1.179.71","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-12-0385"},{"key":"2025121304581129000_67.1.179.72","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.26310"},{"key":"2025121304581129000_67.1.179.73","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310691"},{"key":"2025121304581129000_67.1.179.74","doi-asserted-by":"publisher","DOI":"10.1177\/0969141315609634"},{"key":"2025121304581129000_67.1.179.75","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0140-6736(17)30396-3","article-title":"Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK flexible sigmoidoscopy screening randomised controlled trial","volume":"389","author":"Atkin","year":"2017","journal-title":"Lancet"},{"key":"2025121304581129000_67.1.179.76","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/codi.12220","article-title":"\u2019Be Clear on Cancer': the impact of the UK national bowel cancer awareness campaign","volume":"15","author":"Peacock","year":"2013","journal-title":"Colorectal Dis"},{"key":"2025121304581129000_67.1.179.77","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2012-131014"},{"key":"2025121304581129000_67.1.179.78","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309579"},{"key":"2025121304581129000_67.1.179.79","unstructured":"NICE. Quantitative faecal immunochemical tests to guide referral for colorectal cancer in primary care. https:\/\/www.nice.org.uk\/guidance\/dg30 (accessed 08 Sep 2017)."},{"key":"2025121304581129000_67.1.179.80","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/jamainternmed.2016.0960","article-title":"Nordic-european initiative on colorectal cancer (NordICC) study group. population-based colonoscopy screening for colorectal cancer: a randomized clinical trial","volume":"176","author":"Bretthauer","year":"2016","journal-title":"JAMA Intern Med"},{"key":"2025121304581129000_67.1.179.81","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s13063-015-0826-7","article-title":"Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial","volume":"16","author":"You","year":"2015","journal-title":"Trials"},{"key":"2025121304581129000_67.1.179.82","doi-asserted-by":"crossref","first-page":"djv319","DOI":"10.1093\/jnci\/djv319","article-title":"Reduced and full-preparation CT colonography, fecal immunochemical test, and colonoscopy for population screening of colorectal cancer: a randomized trial","volume":"108","author":"Sali","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"2025121304581129000_67.1.179.83","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.01875.x"},{"key":"2025121304581129000_67.1.179.84","first-page":"935","article-title":"Faecal haemoglobin concentrations by gender and age: implications for population-based screening for colorectal cancer","volume":"50","author":"McDonald","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"2025121304581129000_67.1.179.85","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1002\/cam4.1183","article-title":"Evaluation of a prediction model for colorectal cancer: retrospective analysis of 2.5 million patient records","volume":"6","author":"Birks","year":"2017","journal-title":"Cancer Med"},{"key":"2025121304581129000_67.1.179.86","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1311194"},{"key":"2025121304581129000_67.1.179.87","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3233\/CBM-160321","article-title":"A systematic review of the performance of the SEPT9 gene methylation assay in colorectal cancer screening, monitoring, diagnosis and prognosis","volume":"18","author":"Song","year":"2017","journal-title":"Cancer Biomark"},{"key":"2025121304581129000_67.1.179.88","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.218305"},{"key":"2025121304581129000_67.1.179.89","first-page":"151","article-title":"Circulating tumor cells versus circulating tumor DNA in colorectal cancer: pros and cons","volume":"12","author":"Tan","year":"2016","journal-title":"Curr Colorectal Cancer Rep"},{"key":"2025121304581129000_67.1.179.90","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309800"},{"key":"2025121304581129000_67.1.179.91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12328-016-0710-3","article-title":"Colon capsule endoscopy: toward the future","volume":"10","author":"Muguruma","year":"2017","journal-title":"Clin J Gastroenterol"},{"key":"2025121304581129000_67.1.179.92","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf6219"},{"key":"2025121304581129000_67.1.179.93","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-0510"},{"key":"2025121304581129000_67.1.179.94","doi-asserted-by":"crossref","unstructured":"Brierley JD , Gospodarowicz MK , Wittekind C , eds. TNM classification of malignant tumours. 8th ed. Oxford: Wiley-Blackwell, 2016.","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"key":"2025121304581129000_67.1.179.95","unstructured":"Edge SB . American Joint Committee on Cancer. AJCC cancer staging manual. 7th ed. New York: Springer, 2010."},{"key":"2025121304581129000_67.1.179.96","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/modpathol.2017.46","article-title":"Recommendations for reporting tumor budding in colorectal cancer based on the international tumor budding consensus conference (ITBCC) 2016","volume":"30","author":"Lugli","year":"2017","journal-title":"Mod Pathol"},{"key":"2025121304581129000_67.1.179.97","doi-asserted-by":"publisher","DOI":"10.1002\/path.4287"},{"key":"2025121304581129000_67.1.179.98","unstructured":"Pathology and prognostic determinants of colorectal cancer. https:\/\/www.uptodate.com\/contents\/pathology-and-prognostic-determinants-of-colorectal-cancer (accessed 08 Sep 2017)."},{"key":"2025121304581129000_67.1.179.99","first-page":"93","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more\u00a0\u201cpersonalized\u201d\u00a0approach to\u00a0cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"2025121304581129000_67.1.179.100","doi-asserted-by":"publisher","DOI":"10.1038\/nature11252"},{"key":"2025121304581129000_67.1.179.101","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neo.2017.01.003","article-title":"Single-center experience with a targeted next generation sequencing assay for assessment of relevant somatic alterations in solid tumors","volume":"19","author":"Paasinen-Sohns","year":"2017","journal-title":"Neoplasia"},{"key":"2025121304581129000_67.1.179.102","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70209-6"},{"key":"2025121304581129000_67.1.179.103","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju298"},{"key":"2025121304581129000_67.1.179.104","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-015-1105-3"},{"key":"2025121304581129000_67.1.179.105","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500596"},{"key":"2025121304581129000_67.1.179.106","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3174"},{"key":"2025121304581129000_67.1.179.107","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3175"},{"key":"2025121304581129000_67.1.179.108","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001453","article-title":"Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value","volume":"10","author":"Marisa","year":"2013","journal-title":"PLoS Med"},{"key":"2025121304581129000_67.1.179.109","first-page":"634","article-title":"Embracing an integromic approach to tissue biomarker research in cancer: Perspectives and lessons learned","volume":"18","author":"Li","year":"2017","journal-title":"Brief Bioinform"},{"key":"2025121304581129000_67.1.179.110","doi-asserted-by":"publisher","DOI":"10.1043\/1543-2165-134.6.876"},{"key":"2025121304581129000_67.1.179.111","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19891101)64:9<1937::AID-CNCR2820640929>3.0.CO;2-X"},{"key":"2025121304581129000_67.1.179.112","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/codi.12129","article-title":"Systematic review and meta-analysis of histopathological factors influencing the risk of lymph node metastasis in early colorectal cancer","volume":"15","author":"Beaton","year":"2013","journal-title":"Colorectal Dis"},{"key":"2025121304581129000_67.1.179.113","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1325969"},{"key":"2025121304581129000_67.1.179.114","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1200\/JOP.2016.017210","article-title":"Adjuvant chemotherapy for stage II colon cancer: a clinical dilemma","volume":"13","author":"Kannarkatt","year":"2017","journal-title":"J Oncol Pract"},{"key":"2025121304581129000_67.1.179.115","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61866-2"},{"key":"2025121304581129000_67.1.179.116","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.8261"},{"key":"2025121304581129000_67.1.179.117","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2014-0325"},{"key":"2025121304581129000_67.1.179.118","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032709"},{"key":"2025121304581129000_67.1.179.119","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2006.07.020"},{"key":"2025121304581129000_67.1.179.120","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/modpathol.2016.34","article-title":"Digital image analysis outperforms manual biomarker assessment in breast cancer","volume":"29","author":"St\u00e5lhammar","year":"2016","journal-title":"Mod Pathol"},{"key":"2025121304581129000_67.1.179.121","unstructured":"Life SciencesIndustrial Strategy. A report to the Government from the life sciences sector. https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/ 640696\/life-sciences-industrial-strategy.pdf (accessed 08 Sep 2017)."},{"key":"2025121304581129000_67.1.179.122","unstructured":"Genomics Education Programme. Developing people for health and healthcare. https:\/\/www.genomicseducation.hee.nhs.uk\/ (accessed 08 Sep 2017)."},{"key":"2025121304581129000_67.1.179.123","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPH2A4XTXJUKDZ"},{"key":"2025121304581129000_67.1.179.124","first-page":"CD003432","article-title":"Long-term results of laparoscopic colorectal cancer resection","volume":"2","author":"Kuhry","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121304581129000_67.1.179.125","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(05)70221-7"},{"key":"2025121304581129000_67.1.179.126","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.clon.2016.02.002","article-title":"Wide Variation in the Use of Radiotherapy in the Management of Surgically Treated Rectal Cancer Across the English National Health Service","volume":"28","author":"Morris","year":"2016","journal-title":"Clin Oncol"},{"key":"2025121304581129000_67.1.179.127","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/s13063-015-0972-y","article-title":"Direct improvement of quality of life in colorectal cancer patients using a tailored pathway with quality of life diagnosis and therapy (DIQOL): study protocol for a randomised controlled trial","volume":"16","author":"Klinkhammer-Schalke","year":"2015","journal-title":"Trials"},{"key":"2025121304581129000_67.1.179.128","unstructured":"Department of Oncology. Roosevelt Drive Oxford. https:\/\/www.oncology.ox.ac.uk\/trial\/scot (accessed 08 Sep 2017)."},{"issue":"18_suppl","key":"2025121304581129000_67.1.179.129","doi-asserted-by":"crossref","first-page":"LBA1","DOI":"10.1200\/JCO.2017.35.18_suppl.LBA1","article-title":"Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): the IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration","volume":"35","author":"Shi","year":"2017","journal-title":"J Clin Oncol"},{"key":"2025121304581129000_67.1.179.130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cct.2016.10.004","article-title":"ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours","volume":"51","author":"Coyle","year":"2016","journal-title":"Contemp Clin Trials"},{"key":"2025121304581129000_67.1.179.131","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3747\/co.v15i6.378","article-title":"The colon health and life-long exercise change trial: a randomized trial of the national cancer institute of canada clinical trials group","volume":"15","author":"Courneya","year":"2008","journal-title":"Curr Oncol"},{"key":"2025121304581129000_67.1.179.132","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70348-0"},{"key":"2025121304581129000_67.1.179.133","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h530"},{"key":"2025121304581129000_67.1.179.134","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/codi.12627","article-title":"Report from a consensus meeting: response to chemoradiotherapy in rectal cancer - predictor of cure and a crucial new choice for the patient: on behalf of the Champalimaud 2014 Faculty for \u2019Rectal cancer: when NOT to operate'","volume":"16","author":"Heald","year":"2014","journal-title":"Colorectal Dis"},{"key":"2025121304581129000_67.1.179.135","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00467-2"},{"key":"2025121304581129000_67.1.179.136","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(14)70205-X"},{"key":"2025121304581129000_67.1.179.137","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-015-4157-7"},{"key":"2025121304581129000_67.1.179.138","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1055\/s-0036-1584292","article-title":"The multidisciplinary management of colorectal cancer: present and future paradigms","volume":"29","author":"Sievers","year":"2016","journal-title":"Clin Colon Rectal Surg"},{"key":"2025121304581129000_67.1.179.139","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0b013e31827ca313"},{"key":"2025121304581129000_67.1.179.140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13014-015-0369-9","article-title":"Stereotactic radiation therapy for liver metastases: factors affecting local control and survival","volume":"10","author":"Andratschke","year":"2015","journal-title":"Radiat Oncol"},{"key":"2025121304581129000_67.1.179.141","first-page":"104","article-title":"From molecular biology to clinical trials: toward personalized colorectal cancer therapy","volume":"15","author":"Palma","year":"2016","journal-title":"Clin Colorectal Cancer"},{"key":"2025121304581129000_67.1.179.142","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jss.2017.04.013","article-title":"Personalized treatment in patients with colorectal liver metastases","volume":"216","author":"Moris","year":"2017","journal-title":"J Surg Res"},{"key":"2025121304581129000_67.1.179.143","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrclinonc.2016.79","article-title":"Clinical development of new drug-radiotherapy combinations","volume":"13","author":"Sharma","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"2025121304581129000_67.1.179.144","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61116-8"},{"key":"2025121304581129000_67.1.179.145","unstructured":"Cancer Research UK. Bowel cancer incidence statistics. http:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/bowel-cancer\/incidence#heading Three (accessed 08 Sep 2017)."},{"key":"2025121304581129000_67.1.179.146","unstructured":"National Cancer Institute. Drugs approved for colon and rectal cancer. https:\/\/www.cancer.gov\/about-cancer\/treatment\/drugs\/colorectal (accessed 08 Sep 2017)."},{"key":"2025121304581129000_67.1.179.147","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501824"},{"key":"2025121304581129000_67.1.179.148","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104621"},{"key":"2025121304581129000_67.1.179.149","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504030"},{"key":"2025121304581129000_67.1.179.150","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S1470-2045(17)30422-9","article-title":"Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study","volume":"18","author":"Overman","year":"2017","journal-title":"Lancet Oncol"},{"key":"2025121304581129000_67.1.179.151","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000446490","article-title":"Surgery for colorectal cancer\u00a0\u2013\u00a0trends, developments, and future\u00a0perspectives","volume":"32","author":"Rentsch","year":"2016","journal-title":"Visc Med"},{"key":"2025121304581129000_67.1.179.152","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i38.14018"},{"key":"2025121304581129000_67.1.179.153","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.3748\/wjg.v23.i23.4170","article-title":"Advances in surgical management for locally recurrent rectal cancer: How far have we come?","volume":"23","author":"Lee","year":"2017","journal-title":"World J Gastroenterol"},{"key":"2025121304581129000_67.1.179.154","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1745-6215-13-54","article-title":"Open versus laparoscopic left lateral hepatic sectionectomy within an enhanced recovery ERAS\u00ae programme (ORANGE II-trial): study protocol for a randomised controlled trial","volume":"13","author":"van Dam","year":"2012","journal-title":"Trials"},{"key":"2025121304581129000_67.1.179.155","unstructured":"ISRCTN registry. LAVA: Liver resection surgery versus thermal ablation for colorectal liver metastases. http:\/\/www.isrctn.com\/ISRCTN52040363 (accessed 08 Sep 2017)."},{"key":"2025121304581129000_67.1.179.156","unstructured":"U.S National Library of Medicine. Chemotherapy and Maximal Tumor Debulking of Multi-organ Colorectal Cancer Metastases (ORCHESTRA). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01792934 (accessed 08 Sep 2017)."},{"key":"2025121304581129000_67.1.179.157","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0014"},{"key":"2025121304581129000_67.1.179.158","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2014.08.002"},{"key":"2025121304581129000_67.1.179.159","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2014.11.012"},{"key":"2025121304581129000_67.1.179.160","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf1490"},{"key":"2025121304581129000_67.1.179.161","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan6733"},{"key":"2025121304581129000_67.1.179.162","doi-asserted-by":"publisher","DOI":"10.1126\/science.1129139"},{"key":"2025121304581129000_67.1.179.163","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.freeradbiomed.2016.10.504","article-title":"Microbiome-driven carcinogenesis in colorectal cancer: models and mechanisms","volume":"105","author":"Wang","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"2025121304581129000_67.1.179.164","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2009.08.014"},{"key":"2025121304581129000_67.1.179.165","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv249"},{"key":"2025121304581129000_67.1.179.166","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/DCR.0000000000000618","article-title":"Methodological and reporting quality of comparative studies evaluating health-related quality of life of colorectal cancer patients and controls: a systematic review","volume":"59","author":"Wong","year":"2016","journal-title":"Dis Colon Rectum"},{"key":"2025121304581129000_67.1.179.167","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw425"},{"key":"2025121304581129000_67.1.179.168","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0258"},{"key":"2025121304581129000_67.1.179.169","doi-asserted-by":"crossref","first-page":"e403","DOI":"10.1016\/S1470-2045(12)70236-X","article-title":"Anterior resection syndrome","volume":"13","author":"Bryant","year":"2012","journal-title":"Lancet Oncol"},{"key":"2025121304581129000_67.1.179.170","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(07)70341-8"},{"key":"2025121304581129000_67.1.179.171","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/DCR.0000000000000552","article-title":"Predicting the risk of bowel-related quality-of-life impairment after restorative resection for rectal cancer: a multicenter cross-sectional study","volume":"59","author":"Battersby","year":"2016","journal-title":"Dis Colon Rectum"},{"key":"2025121304581129000_67.1.179.172","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/DCR.0b013e3182214f11","article-title":"The long-term gastrointestinal functional outcomes following curative anterior resection in adults with rectal cancer: a systematic review and meta-analysis","volume":"54","author":"Scheer","year":"2011","journal-title":"Dis Colon Rectum"},{"key":"2025121304581129000_67.1.179.173","doi-asserted-by":"publisher","DOI":"10.1080\/02841860701348670"},{"key":"2025121304581129000_67.1.179.174","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1111\/codi.12036","article-title":"Treatment options to improve anorectal function following rectal resection: a systematic review","volume":"15","author":"Maris","year":"2013","journal-title":"Colorectal Dis"},{"key":"2025121304581129000_67.1.179.175","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/nau.22654","article-title":"Pelvic floor muscle training for bowel dysfunction following colorectal cancer surgery: a systematic review","volume":"34","author":"Lin","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"2025121304581129000_67.1.179.176","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3393\/ac.2014.30.3.109","article-title":"Pelvic floor rehabilitation to improve functional outcome after a low anterior resection: a systematic review","volume":"30","author":"Visser","year":"2014","journal-title":"Ann Coloproctol"},{"key":"2025121304581129000_67.1.179.177","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S1470-2045(15)00461-1","article-title":"Hyperbaric oxygen for patients with chronic bowel dysfunction after pelvic radiotherapy (HOT2): a randomised, double-blind, sham-controlled phase 3 trial","volume":"17","author":"Glover","year":"2016","journal-title":"Lancet Oncol"},{"key":"2025121304581129000_67.1.179.178","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61648-7"},{"key":"2025121304581129000_67.1.179.179","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2014-100468"},{"key":"2025121304581129000_67.1.179.180","doi-asserted-by":"crossref","first-page":"S518","DOI":"10.1016\/j.amepre.2015.08.007","article-title":"Factors associated with health-related quality of life among colorectal cancer survivors","volume":"49","author":"Rodriguez","year":"2015","journal-title":"Am J Prev Med"},{"key":"2025121304581129000_67.1.179.181","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21265"},{"key":"2025121304581129000_67.1.179.182","doi-asserted-by":"crossref","first-page":"52095","DOI":"10.18632\/oncotarget.10603","article-title":"Pre- and post-diagnosis physical activity is associated with survival benefits of colorectal cancer patients: a systematic review and meta-analysis","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"2025121304581129000_67.1.179.183","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00384-016-2671-x","article-title":"Cancer survivor study (CASUS) on colorectal patients: longitudinal study on physical activity, fitness, nutrition, and its influences on quality of life, disease recurrence, and survival. Rationale and design","volume":"32","author":"Soares-Miranda","year":"2017","journal-title":"Int J Colorectal Dis"},{"key":"2025121304581129000_67.1.179.184","doi-asserted-by":"crossref","unstructured":"Alfano CM , Bluethmann SM , Tesauro G , et al . NCI funding trends and priorities in physical activity and energy balance research among cancer survivors. J Natl Cancer Inst 2016;108.doi:10.1093\/jnci\/djv285","DOI":"10.1093\/jnci\/djv285"},{"key":"2025121304581129000_67.1.179.185","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.51.7540"},{"key":"2025121304581129000_67.1.179.186","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101170","article-title":"Clinical and organizational issues in the management of surviving breast and colorectal cancer patients: attitudes and feelings of medical oncologists","volume":"9","author":"Numico","year":"2014","journal-title":"PLoS One"},{"key":"2025121304581129000_67.1.179.187","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28063"},{"issue":"Suppl 1","key":"2025121304581129000_67.1.179.188","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/bjc.2011.416","article-title":"The National Cancer Survivorship Initiative: new and emerging evidence on the ongoing needs of cancer survivors","volume":"105","author":"Richards","year":"2011","journal-title":"Br J Cancer"},{"key":"2025121304581129000_67.1.179.189","unstructured":"Macmillan Cancer Support. Care after Cancer. http:\/\/www.macmillan.org.uk\/documents\/getinvolved\/campaigns\/campaigns\/survivorship\/survivorshipreport2009.pdf (accessed 08 Sep 2017)."},{"key":"2025121304581129000_67.1.179.190","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21286"},{"key":"2025121304581129000_67.1.179.191","unstructured":"Global Alliance for Genomics and Health. Enabling genomic data sharing for the benefit of human health. https:\/\/genomicsandhealth.org\/ (accessed 08 Sep 2017)."},{"key":"2025121304581129000_67.1.179.192","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4089"},{"key":"2025121304581129000_67.1.179.193","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMp1612254","article-title":"Sharing clinical and genomic data on cancer \u2013 the need for global\u00a0solutions","volume":"376","author":"Lawler","year":"2017","journal-title":"N Engl J Med"},{"key":"2025121304581129000_67.1.179.194","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2015.02.002"},{"key":"2025121304581129000_67.1.179.195","first-page":"96","article-title":"Limits to precision cancer medicine","volume":"376","author":"Tannock","year":"2017","journal-title":"N Engl J Med"},{"key":"2025121304581129000_67.1.179.196","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-366"},{"key":"2025121304581129000_67.1.179.197","doi-asserted-by":"publisher","DOI":"10.1097\/01.cej.0000136575.01493.9b"},{"key":"2025121304581129000_67.1.179.198","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/cncr.24186","article-title":"Colon cancer patient information seeking and the adoption of targeted therapy for on-label and off-label indications","volume":"115","author":"Gray","year":"2009","journal-title":"Cancer"},{"key":"2025121304581129000_67.1.179.199","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejon.2015.08.005","article-title":"Knowledge and awareness of long-term and late treatment consequences amongst colorectal cancer survivors: a qualitative study","volume":"20","author":"Brown","year":"2016","journal-title":"Eur J Oncol Nurs"},{"key":"2025121304581129000_67.1.179.200","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a1655"},{"key":"2025121304581129000_67.1.179.201","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h1258"},{"key":"2025121304581129000_67.1.179.202","unstructured":"Cancer Research UK. Understanding gpattitudes to cancerpreventing drugs. http:\/\/www.cancerresearchuk.org\/sites\/default\/files\/understanding_gp_attitudes_to_cancer_preventing_drugs_full_evidence_report.pdf (accessed 08 Sep 2017)."},{"key":"2025121304581129000_67.1.179.203","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-002317","article-title":"Patient-reported outcomes of cancer survivors in england 1-5 years after diagnosis: a cross-sectional survey","volume":"3","author":"Glaser","year":"2013","journal-title":"BMJ Open"},{"key":"2025121304581129000_67.1.179.204","doi-asserted-by":"crossref","first-page":"O217","DOI":"10.1111\/codi.13021","article-title":"Synthesis and summary of patient-reported outcome measures to inform the development of a core outcome set in colorectal cancer surgery","volume":"17","author":"McNair","year":"2015","journal-title":"Colorectal Dis"},{"key":"2025121304581129000_67.1.179.205","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1470-2045(13)70552-7","article-title":"European Cancer Concord (ECC)","volume":"15","author":"Lawler","year":"2014","journal-title":"Lancet Oncol"},{"key":"2025121304581129000_67.1.179.206","doi-asserted-by":"crossref","first-page":"pii: dju216","DOI":"10.1093\/jnci\/dju216","article-title":"Discussions about clinical trials among patients with newly diagnosed lung and colorectal cancer","volume":"106","author":"Kehl","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"2025121304581129000_67.1.179.207","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0279"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2017-315333","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T12:58:25Z","timestamp":1765630705000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2017-315333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,12]]},"references-count":207,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12,12]]},"published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1136\/gutjnl-2017-315333"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2017-315333","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,12]]}}}